Enter a Search String |
| Special character and space not allowed in the query term. Search string should be at least 2 characters long. |
Molecule Parameter List for IP3(145) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The statistics table lists the distribution of a molecule acting either as a substrate, product, enzyme or as a molecule within the network. The text color of a molecule is highlighted by color. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Statistics | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IP3(145) participated as | Molecule | Sum total of | Enzyme | Substrate of an enzyme | Product of an enzyme | Substrate in Reaction | Product in Reaction |
| No. of occurrences | 1 | 1 | 0 | 7 | 5 | 1 | 3 |
Accession and Pathway Details |
| Accession Name | Accession No. | Accession Type | Pathway Link |
IP3metabolism | 24 | Network | MIPP, CaMKII, CaM, PKC, IP3-3K, Gq, PLCbeta, 134_dephos, 145_dephos, IP4-system, IHP-system, 1345_dephos, CaRegulation, Othmer-Tang-model |
| This network models an oscillatory calcium response to GPCR mediated PLCbeta activation, alongwith detailed InsP3 metabolism in the neuron. It differs from the NonOsc_Ca_IP3metabolism network in the CaRegulation module and in InsP3 receptor kinetics. Details of InsP3 receptor kinetics have been adapted from the Othmer-Tang model for oscillatory Ca dynamics. Mishra J, Bhalla US. Biophys J. 2002 Sep;83(3):1298-316. | |||
IP3(145) acting as a Molecule in Osc_Ca_IP3metabolism Network
| Name | Accession Name | Pathway Name | Initial Conc. (uM) | Volume (fL) | Buffered | |
| IP3(145) | IP3metabolism Accession No. : 24 | 145_dephos Pathway No. : 128 | 0.2 | 1000 | No | |
| Inositol (145)trisphosphate | ||||||
IP3(145) acting as a Summed Molecule in Osc_Ca_IP3metabolism Network
| Accession Name | Pathway Name | Target | Input |
IP3metabolism Accession No. : 24 | l Pathway No. : 133 | IP3 | IP3(145) |
| Inositol(145)trisphosphate in the cytoplasm. Levels are determined by the IP3-metabolism network | |||
IP3(145) acting as a Substrate for an Enzyme in Osc_Ca_IP3metabolism Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents | |
| 1 | IP3_3K / ip3-3k | IP3metabolism Accession No. : 24 | IP3-3K Pathway No. : 124 | 1.40001 | 3.0475 | 4 | explicit E-S complex | Substrate IP3(145) Product IP4(1345) |
| from Johanson et al, JBC 263; 1988 Original Vmax scaled up by 50% to obtain value at 37C, as enzyme assay was done at 30C Km increased from 0.2 to 1.4 as per various other reports (Shears Review, BiochemJ 260; 1989) | ||||||||
| 2 | IP3_3K*1 / ip3-3k*1 | IP3metabolism Accession No. : 24 | IP3-3K Pathway No. : 124 | 1.40004 | 0.76187 | 4.00003 | explicit E-S complex | Substrate IP3(145) Product IP4(1345) |
| from Sim et al, JBC 265; 1990 | ||||||||
| 3 | IP3_3K* / ip3-3k* | IP3metabolism Accession No. : 24 | IP3-3K Pathway No. : 124 | 1.40001 | 3.0475 | 4 | explicit E-S complex | Substrate IP3(145) Product IP4(1345) |
| from Communi et al, EMBO J 16; 1997 In absence of CaM binding, activity same as that of non-phosphorylated enzyme | ||||||||
| 4 | IP3_3K_CaM* / ip3-3k-CaM* | IP3metabolism Accession No. : 24 | IP3-3K Pathway No. : 124 | 2.80002 | 45 | 4 | explicit E-S complex | Substrate IP3(145) Product IP4(1345) |
| from Communi et al, EMBO J 16; 1997 Vmax adjusted to obtain 9-fold greater activity than ip3-3k | ||||||||
| 5 | IP3_3K_CaM / ip3-3k-CaM | IP3metabolism Accession No. : 24 | IP3-3K Pathway No. : 124 | 2.8001 | 10.5 | 4.0001 | explicit E-S complex | Substrate IP3(145) Product IP4(1345) |
| from Erneux et al, Biochem 214; 1993 2-2.5 fold more active than ip3-3k but Km is doubled, hence Vmax adjusted accordingly. | ||||||||
| 6 | IP3_5pase2 / ip3_5pase2 | IP3metabolism Accession No. : 24 | 145_dephos Pathway No. : 128 | 18.0004 | 10.667 | 3.99991 | explicit E-S complex | Substrate IP3(145) Product IP2(14) |
| from Hansen et al, JBC 262, 1987 activity determined from pH curve. Value scaled 1.5 times to obtain activity at 37C as original experiment was performed at 30C | ||||||||
| 7 | IP_5pase1 / ip3_5pase1 | IP3metabolism Accession No. : 24 | 145_dephos Pathway No. : 128 | 3.00001 | 1.1 | 4 | explicit E-S complex | Substrate IP3(145) Product IP2(14) |
| Ins(145)P3 5-phosphatase activity of InsP-5-phosphatase from Hansen et al, JBC 262; 1987 | ||||||||
IP3(145) acting as a Product of an Enzyme in Osc_Ca_IP3metabolism Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents | |
| 1 | PLC-Gq / PLC-Gq | IP3metabolism Accession No. : 24 | PLCbeta Pathway No. : 126 | 5 | 75 | 4 | explicit E-S complex | Substrate PIP2 Product DAG IP3(145) |
| from Smrcka et al, 1991 Science 251: 804-807 | ||||||||
| 2 | PLC-Ca / PLC-Ca | IP3metabolism Accession No. : 24 | PLCbeta Pathway No. : 126 | 19.8408 | 10 | 4 | explicit E-S complex | Substrate PIP2 Product DAG IP3(145) |
| From Sternweis et al Phil Trans R Soc Lond 1992, also matched by Homma et al. k1 = 1.5e-5, now 4.2e-6 k2 = 70/sec; now 40/sec k3 = 17.5/sec; now 10/sec Note that the wording in Sternweis et al is ambiguous re the Km. Also Smrcka et al; Science 251, 15.2.1991, pp804-807 | ||||||||
| 3 | PLC-Ca-Gq / PLCb-Ca-Gq | IP3metabolism Accession No. : 24 | PLCbeta Pathway No. : 126 | 4.99994 | 160 | 4 | explicit E-S complex | Substrate PIP2 Product DAG IP3(145) |
| Km: Sternweis et al, Phil Trans R Soc Lond 1992 Vmax: Smrcka et al, Science 1991 | ||||||||
| 4 | PLC / PLC | IP3metabolism Accession No. : 24 | PLCbeta Pathway No. : 126 | 19.9994 | 2.5 | 4 | explicit E-S complex | Substrate PIP2 Product DAG IP3(145) |
| Smrcka et al; Science 251, 15.2.1991, pp804-807 | ||||||||
| 5 | 1345_3pase / ip4_3pase | IP3metabolism Accession No. : 24 | 1345_dephos Pathway No. : 131 | 0.400007 | 0.0012 | 4 | explicit E-S complex | Substrate IP4(1345) Product IP3(145) |
| Ins(1345)P4 3-phosphatase from Nogimori et al, JBC 266; 1991 | ||||||||
IP3(145) acting as a Substrate in a reaction in Osc_Ca_IP3metabolism Network
| Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated. Kd for higher order reaction are not consider. |
| Name | Accession Name | Pathway Name | Kf | Kb | Kd | tau | Reagents |
| 145-inhib-3pase | IP3metabolism Accession No. : 24 | 1345_dephos Pathway No. : 131 | 1 (uM^-1 s^-1) | 1.75 (s^-1) | Kd(bf) = 1.75(uM) | - | Substrate 1345_3pase IP3(145) Product mplx |
| from Hoer et al, Biochem J 270; 1990 | |||||||
IP3(145) acting as a Product in a reaction in Osc_Ca_IP3metabolism Network
| Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated. Kd for higher order reaction are not consider. |
| Name | Accession Name | Pathway Name | Kf | Kb | Kd | tau | Reagents | |
| 1 | ip3(145)_trp | IP3metabolism Accession No. : 24 | MIPP Pathway No. : 120 | 1 (s^-1) | 0.001 (s^-1) | Not applicable** | - | Substrate IP3(145)_ER Product IP3(145) |
| Ins(145)P3 ER-cytosol transport | ||||||||
| 2 | basal | IP3metabolism Accession No. : 24 | PLCbeta Pathway No. : 126 | 0.003 (s^-1) | 0 (uM^-1 s^-1) | - | - | Substrate PIP2 Product DAG IP3(145) |
| accounts for other PLC isoforms that contribute to basal levels of IP3 | ||||||||
| 3 | ip4-6pase | IP3metabolism Accession No. : 24 | IP4-system Pathway No. : 129 | 0.01 (s^-1) | 0 (s^-1) | - | - | Substrate IP4(1456) Product IP3(145) |
| this step is essential to maintain flux around the network, rate adjusted accordingly | ||||||||
color.